The Top Stories shaping the Pharma Industry right now show a clear shift—global deals, AI-led innovation, and policy clarity are driving momentum. From major acquisitions to breakthrough trials and public health moves, these updates reflect...
Zydus Lifesciences has expanded its presence in France healthcare market with a €700,000 acquisition of FBC Medical, a move that strengthens its position in the medical equipment distribution sector. The deal marks another step in the compan...
The Centre has relaxed CME rules, medtech firms, and UCMPMD code requirements, making it easier for companies to organise training and educational programmes for healthcare professionals. The revised policy aims to reduce approval delays whil...
India’s pharmaceutical sector is under renewed focus after Lilly supported Haryana’s crackdown on fake Mounjaro drug networks, following the seizure of counterfeit products in Gurugram. The action by the Haryana State Food and Drug Administra...
Abbott has announced a major leap in AI coronary imaging with regulatory clearances for its new Ultreon 3.0 platform. The system has received approval from the U.S. Food and Drug Administration and the CE Mark, signaling readiness for use in...
Pfizer Inc. has reported strong topline results from its phase 3 MagnetisMM-5 study, signaling a potential shift in myeloma treatment for patients with relapsed or refractory disease. The trial showed that Elrexfio significantly improved...
RPG Life Sciences is sharpening its strategy today with a strong focus on its GLP-1 entry plan and expanding API business, signaling a shift toward high-growth pharmaceutical segments. The company is looking to strengthen its position in active...
Abbott announced it has secured U.S. Food and Drug Administration clearance and CE Mark approval for its latest OCT imaging system, Ultreon 3.0, signaling a major move in complex coronary care. The platform combines high-resolution imaging with...
Indegene Q4 FY26 revenue crossed a major milestone, but profits told a different story. The company reported revenue of Rs 1,003 crore for the quarter, marking a strong 32.8 percent year-on-year growth and its first time breaching the...
Solara Active Pharma Sciences has successfully cleared a US FDA inspection at its Puducherry manufacturing plant, earning a Voluntary Action Indicated (VAI) status and reinforcing its compliance with global pharmaceutical quality standar...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")